1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirobe, M; Kotake, Y; Ohta, S; Okuda, K; Sekiya, Y; Taguchi, R; Tasaki, Y | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Polak, D; Romańska, I; Wąsik, A | 1 |
| Antkiewicz-Michaluk, L; Romańska, I; Wąsik, A; Zelek-Molik, A | 1 |
3 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and oxidopamine
| Article | Year |
|---|---|
Neuroprotective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on cultured rat mesencephalic neurons in the presence or absence of various neurotoxins.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidopamine; Pregnancy; Rats; Rats, Wistar; Rotenone; Tetrahydroisoquinolines | 2005 |
The impact of 1MeTIQ on the dopaminergic system function in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines | 2016 |
Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Topics: Analysis of Variance; Animals; Corpus Striatum; Dopamine; Exploratory Behavior; Functional Laterality; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Oxidopamine; Rats; Rats, Wistar; Sympatholytics; Tetrahydroisoquinolines; Time Factors; Tyrosine 3-Monooxygenase | 2018 |